Eurogentec

Eurogentec Eurogentec is a leading provider of trusted and innovative products and services to the Life-Science Experts in microbial production (E. coli, P.

Kaneka Eurogentec S.A., part of Kaneka Corporation, is a leading global supplier of innovative reagents, kits, specialty products and custom services. Through its three inter-related business units (BU), the company provides high quality products to scientists involved in the life science, biotechnology, diagnostic and pharmaceutical markets. Eurogentec is fully ISO 9001, ISO 13485 certified, cGMP

accredited by the Belgian Ministry of Health and approved by the US FDA for the commercial manufacturing of a biologic for the US market. The Life Science Research BU is specialized in innovative solutions in Genomics and Proteomics. Expert in small and large-scale synthesis, Eurogentec proposes a wide range of reagents, kits and consumables for Life Science applications such as Custom Oligonucleotides, high performance PCR/qPCR Kits & Reagents (including high pure Diamond Taq® DNA Polymerases), catalogue dyes, peptides & antibodies. Eurogentec is also specialist in the design and synthesis of custom peptides and production of custom antibodies (including a 28-day Speedy protocol) as well as producing pre-dispensed assays in a GMP environment. The In Vitro Diagnostics BU provides technical and project support for contract manufacturing of GMP oligonucleotides and Taq DNA polymerases for use in Molecular Diagnostic applications. As a certified ISO 13485 and GMP compliant manufacturer, our manufacturing processes take place in classified clean rooms with controlled processes and full traceability. Our production facilities in Belgium and US enable high quality materials for the in vitro Diagnostic community. The GMP BioManufacturing BU is a full-service Contract Manufacturing Organization (CMO) and offers significant know-how in process development, technology transfer, formulation, scale-up and manufacturing of GMP proteins, protein conjugates, plasmids and bacterial vaccines for pre-clinical, clinical and commercial uses, all according to FDA and EMA requirements. pastoris, etc), Eurogentec offers various development strategies based on protein refolding, periplasmic expression, and protein expression by secretion. As a one-stop shop, Eurogentec provides a complete gene to injectable service offering.

We’re heading to   !Join Eurogentec at Booth  #5451 to explore our GMP therapeutic manufacturing solutions and discuss h...
19/06/2026

We’re heading to !
Join Eurogentec at Booth #5451 to explore our GMP therapeutic manufacturing solutions and discuss how we can help accelerate your drug development.
See you in San Diego!
👉 Schedule a meeting with our team through the BIO Partnering™ platform.

Why consider VHH-Fc fusion proteins?Developing biologics often requires balancing key parameters such as tissue pe******...
18/06/2026

Why consider VHH-Fc fusion proteins?

Developing biologics often requires balancing key parameters such as tissue pe*******on, effective target binding, and half-life in vivo.

VHH-Fc fusion proteins provide a strategy to address these challenges by combining VHH specificity with Fc-driven properties. This format enables:

• Extended half-life through FcRn-mediated recycling
• Stronger target binding through bivalent design
• Engagement of immune effector functions (ADCC, CDC) depending on the expression system
• Improved access to sterically constrained targets
• Flexible design of multi-specific constructs

At Eurogentec, we help you explore and enable advanced VHH-based formats. Discuss your project with our team: https://eu1.hubs.ly/H0wcpLj0

Are you detecting SNPs, low-abundance targets, or 𝘪𝘯 𝘴𝘪𝘵𝘶 targets?Then you may already know LNA® probes…But are you full...
11/06/2026

Are you detecting SNPs, low-abundance targets, or 𝘪𝘯 𝘴𝘪𝘵𝘶 targets?
Then you may already know LNA® probes…But are you fully leveraging their potential?

In our latest blog, we explore how LNA® probes make a real difference in precision diagnostic assays.

📖 Read the article: https://eu1.hubs.ly/H0v-VGz0

®

👟💙 2,335 participants. 110 Eurogentec colleagues. One great cause.For the 20th edition of the "Jogging Entreprises - ULi...
08/06/2026

👟💙 2,335 participants. 110 Eurogentec colleagues. One great cause.
For the 20th edition of the "Jogging Entreprises - ULiege", Team Eurogentec once again came together at Liege Science Park to support the fight against leukodystrophies, , alongside the ELA Association.
An afternoon filled with energy, solidarity, team spirit, and smiles — proving that every step counts for a good cause.
Thank you to everyone who laced up their shoes and joined the movement!

Detect foodborne pathogens with confidence.Takyon® Etheris delivers reliable and accurate microbial DNA detection for fo...
07/06/2026

Detect foodborne pathogens with confidence.
Takyon® Etheris delivers reliable and accurate microbial DNA detection for food, beverage, and dairy testing, helping you validate hygiene and HACCP procedures with clear, trustworthy results.

Meet Takyon® Etheris: https://eu1.hubs.ly/H0vTKfd0

Meet our team this June!We’re excited to be attending several key biotech events this month. Let’s connect and discuss y...
05/06/2026

Meet our team this June!

We’re excited to be attending several key biotech events this month. Let’s connect and discuss your next project!
Book a meeting with our experts now 👉 https://eu1.hubs.ly/H0vX-fl0






VHH antibodies are no longer niche research tools.They’re becoming a major force in next-generation biologics.Our latest...
02/06/2026

VHH antibodies are no longer niche research tools.
They’re becoming a major force in next-generation biologics.

Our latest article explores:
🔹 Current clinical applications
🔹 Emerging delivery strategies (mRNA & oral VHHs)
🔹 AI-driven VHH discovery
🔹 Key manufacturing and developability trends

Discover why VHHs are reshaping the future of antibody engineering.
👉 Read the blog: https://eu1.hubs.ly/H0vNMVJ0

We’re pleased to announce that siRNA duplexes are now available in our ScreenToLead™ service.This addition extends our o...
28/05/2026

We’re pleased to announce that siRNA duplexes are now available in our ScreenToLead™ service.
This addition extends our offering beyond A*O, supporting your screening projects with greater flexibility.
• Designed for early discovery
• From screening to lead selection

Learn more: https://eu1.hubs.ly/H0vFdRS0

*O

When reliable results matter, your qPCR mix counts.Takyon® Etheris delivers cleaner NTCs and lower background than stand...
19/05/2026

When reliable results matter, your qPCR mix counts.
Takyon® Etheris delivers cleaner NTCs and lower background than standard solutions for microbial detection assays.

Compare Now: https://eu1.hubs.ly/H0vj6cQ0

Visit us at booth  #800 at  ! in Boston until May 14!Our team will be delighted to discuss how we can support your oligo...
13/05/2026

Visit us at booth #800 at ! in Boston until May 14!

Our team will be delighted to discuss how we can support your oligonucleotide and peptide programs.

Discover our full range of capabilities, from research-use materials to GMP-grade manufacturing, supporting early discovery, IND-enabling studies, and early-phase clinical development.

We look forward to meeting you in person and exploring how we can support your next projects.

Adres

Rue Du Bois Saint-Jean 5
Seraing
4102

Openingstijden

Maandag 07:30 - 18:00
Dinsdag 07:30 - 18:00
Woensdag 07:30 - 18:00
Donderdag 07:30 - 18:00
Vrijdag 07:30 - 18:00

Telefoon

+3243727400

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer Eurogentec nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Contact

Stuur een bericht naar Eurogentec:

Delen